For patient home delivery:
For inpatient orders:
Recordati Rare Diseases is committed to reducing financial barriers regarding CYSTADANE.
The following programs are available to assist your patients:
Assists eligible patients with their insurance copayments or co-insurance for CYSTADANE.
Helps eligible uninsured or underinsured patients get CYSTADANE.
Anovo will be able to determine whether your patients are eligible for these programs.
Cystadane is a methylating agent indicated in pediatric and adult patients for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations. Included within the category of homocystinuria are: